MSB 4.39% $1.09 mesoblast limited

Snippets from the SMH articleChief executive Silviu Itescu said...

  1. 442 Posts.
    lightbulb Created with Sketch. 45
    Snippets from the SMH article

    Chief executive Silviu Itescu said Australia and the world would need ongoing treatment options for coronavirus, even if a vaccine for the deadly virus is discovered."We all hope the vaccine will come around, but we have to be realistic," Dr Itescu said. "Even with vaccines, treatments like ours are still going to be necessary."The US Data Safety Monitoring board, which reviews clinical data, had selected a date in early September to complete an initial review of Mesoblast's phase 3 trial, the company said. There are no approved treatments for this kind of respiratory distress, and it is not yet known whether its product will prove safe and effective in a large group of patients.Dr Itescu said the company would know the results by the end of this calendar year. If the project is successful, the product could be manufactured in Australia for export into global markets to treat COVID patients around the world.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
-0.050(4.39%)
Mkt cap ! $1.244B
Open High Low Value Volume
$1.14 $1.17 $1.07 $8.385M 7.489M

Buyers (Bids)

No. Vol. Price($)
1 8500 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 26954 3
View Market Depth
Last trade - 16.10pm 19/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.